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Abstract 
Small ubiquitin-like modifiers (SUMO) work in a similar way as ubiquitin to alter the bio-
logical properties of a target protein by conjugation. A shrimp SUMO cDNA named 
LvSUMO-1 was identified in Litopenaeus vannamei. LvSUMO-1 cDNA contains a coding se-
quence of 282 nucleotides with untranslated regions of 37 bp at 5’-end and 347 bp at 3’-end, 
respectively. The deduced 93 amino acids exhibit 83% identity with the Western Honeybee 
SUMO-1, and more than 65% homologies with human and mouse SUMO-1. LvSUMO-1 
mRNA is expressed in most L. vannamei tissues with the highest level in hepatopancrease. 
The mRNA expression of LvSUMO-1 over development stages in L. Vammamei is distin-
guished by a low level in nauplius stage and relatively high level in postlarva stage with con-
tinuous expression until juvenile stage. The LvSUMO-1 protein and its conjugated proteins 
are detected in both cytoplasm and nucleus in several tissues. Interestingly, LvSUMO-1 
mRNA levels are high in abdominal muscle during the premolt stage, wherein it has signifi-
cant activities of protein degradation, suggesting its possible role in the regulation of shrimp 
muscle protein degradation. 
Key words: Invertebrate, Small ubiquitin-like modifiers, Sumoylation, RT-PCR, mRNA, Gene ex-
pression 
Introduction 
 
Small ubiquitin-like modifiers (SUMO) work in 
a similar way as ubiquitins to conjugate a target pro-
tein (sumoylation) to alter the properties of the modi-
fied protein even though it has only 20% identity 
with ubiquitin in mRNA sequence (1). Sumoylation 
has been indicated to regulate the stability of protein 
function, nuclear cytoplasm protein transport and 
gene transcription. Three members of the SUMO 
family have been described in vertebrates, SUMO-1, 
SUMO-2 and SUMO-3 (2). In invertebrates, such as 
yeast, insects and nematodes, only a single SUMO 
gene termed SMT3 is expressed (3), whereas in plants 
up to eight version of SUMO are expressed (4).   
SUMO-1 has been reported with various syno-
nyms, such as GMP1, PIC1, sentrin, UBL1 or SMT3 
(5-9). The first mammalian protein shown to be su-
moylated was RanGAP1, a GTPase-activating pro-
tein, which is known to play an important role in 
transport of proteins across the nuclear pore complex. Int. J. Biol. Sci. 2009, 5 
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Sumoylation facilitates the binding of RanGAP1 to 
nuclear pore, and changes its intracellular localization 
(6, 9, 10). SUMO-1 modifications of heat shock tran-
scription factors (HSF1 and HSF2) increase their DNA 
binding activities while blocking the modifications by 
mutation decreases HSF1 transcriptional activity 
(11,12). Similarly, SUMO-1 modified p53 tumor sup-
pressor by increasing its transcriptional and apoptotic 
response. The sumoylation sites in p53 are located in 
the carboxy-terminal region, which is known to 
regulate its DNA binding activity (3, 13,14). Another 
transcription factor, nuclear factor of activated T cell 
(NFAT), can be sumoylated on the residues K684 and 
K897 when treated with phorbol ester and calcium 
ionophore (15). In addition, several other transcrip-
tion factors were reported to undergo SUMO modifi-
cations, including Ets transcription factor (16-18), an-
drogent receptor (19-21), c-Myb(22), AP-2 (22,23) and 
c-Jun (Muller et al., 2000). SUMO-1 modification can 
also enhance the transcriptional activity of the trans-
forming growth factor β (TGF-β) signaling proteins 
(24,25). One of the TGF-β signaling proteins, namely 
Smad4, was identified as a target protein for SUMO-1 
at two evolutionarily conserved lysine residues 
(Lys-113 and Lys-159) in the MH1 domain. Sumoyla-
tion of Smad4 by over-expression of SUMO-1 en-
hanced transcriptional responses and cellular re-
sponses induced by TGF-β (24). Another TGF-β sig-
nal protein, SnoN, is also regulated by sumoylation. 
Loss of sumoylation in the Lys-50 site (via a 
Lys-to-Arg point mutation) in SnoN potently acti-
vates muscle-specific gene expression and enhances 
myotube formation. These results suggests that 
SUMO modification plays an important role in regu-
lation of myogenic differentiation (25).   
Sumoylation in invertebrate was mainly re-
ported in Drosophila. Transcriptional repressor Tram-
track69 protein (Ttk69), which inhibits neuronal dif-
ferentiation, was identified as one of the most impor-
tant substrates for SUMO conjugation. SUMO and 
Ttk69 proteins localize together on polytene chromo-
some. SUMO-conjugated Ttk69 proteins are present 
at the sites of Ttk69 action in vivo (26). Pacific white 
shrimp (Litopeanaeu Vannamei) is one of the most im-
portant seafood products in the United States and 
Asia. Previously, abdominal muscle cDNA library of 
L. Vannamei was constructed by our laboratory (27). 
While we performed phage lift hybridization of the 
cDNA library by using TGF-β degenerated oligonu-
cleotide DNA probes, a DNA sequence similar to 
SUMO-1 cDNA, named LvSUMO-1, was identified. 
We reported here LvSUMO-1 cDNA sequences and 
its expressions in various tissues during early devel-
opment stages and different molting stages in L. van-
namei. Its expression patterns in abdominal muscle 
over several molting stages suggest its possible role 
in the regulation of shrimp muscle protein degrada-
tion.  
Materials and Methods 
Animals, tissue sampling and RNA extraction 
Cultured specific pathogens-free (SPF) nauplius, 
postlarvae and 3-month-old L. vannamei from a local 
shrimp farm in Honolulu HI were transported alive 
in plastic bags with 1/3 water and 2/3 compressed 
air to the lab. Fresh tissue samples were collected for 
RNA and protein extractions. The tissue samples 
from 3-month-old shrimp include heart (H), eyestalk 
(E), intestine (I), hepatopancreas (Hep), haemocyte 
(Cy), lymphoid (L), brain and nerve ganglion (BN), 
gill (G), pleopods (P), abdominal muscle (AM), 
swimming leg muscle (SM) and ovary (O). The tis-
sues samples used for molt stage studies were from a 
previous report (28). Total RNA was isolated by 
TRIZOL Reagent (Invitrogen), following the method 
described by Yang et al (29). Briefly, 100 mg of tissue 
was homogenized in 1ml TRIZOL reagent using a 
Polytron homogenizer (Model PT 10/35, Brinkmann 
Instruments, Westbury, NY). Homogenized sample 
was incubated for 7 min at room temperature follow 
by chloroform (0.2 ml per ml of TRIZOL) added. The 
tube was vigorously shaken by hand and incubated 
at room temperature for 5 min. Following centrifuga-
tion at 12,000 rpm for 15 min at 4°C, the aqueous 
phase was transferred to a clean tube to which iso-
propanol was added. After 15 min incubation at room 
temperature, tubes were centrifuged at 4°C for 15 min 
at 12,000 rpm, and supernatant was withdrawn and 
remaining RNA pellets were washed with 70% etha-
nol, allowed to dry for 10–15 min, dissolved in de-
ionized-distilled water and stored in -80°C. Total 
RNA concentrations were calculated by spectropho-
tometer. 
Screening of abdominal muscle cDNA library 
oligonucleotide probe  
A phages cDNA library was constructed with 
the mRNA isolated from Litopenaeus vannamei ab-
dominal muscle of juvenile animals (28) by using the 
SMART cDNA library construction kit (Clontech). 
High-density filters corresponding to a shrimp mus-
cle phage cDNA library was represented by two 
high-density filters with 10,000 plaques spotted on 
each membrane. A total of six degenerated oligonu-
cleotide DNA probes designed by comparison of the 
c-terminal conserved region of TGF-β mRNA se-
quences were labeled with biotin (www.idtdna.com). 
Hybridization was done as described (30) in hybridi-Int. J. Biol. Sci. 2009, 5 
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zation oven. After hybridization, the filters were 
washed in 2x SSC, 0.1% SDS 2 times for 15 min at 
room temperature and once for 15 min at 50˚C of 0.1x 
SSC, 0.1%SDS. Blots were autoradiographed for em-
pirically optimized exposure times by using 
CDP-Star® Chemiluminescence reagent as substrate 
for streptavidin alkaline phosphatase conjugates.   
Positive phage conversion 
Individual positive plaques were excised from 
plates and incubated overnight at 4˚C in 350 ul 1x 
phage elution buffer (0.1M NaCl, 0.01M MgSO4, 
0.035M Tris-HCl, pH7.5, 0.01% Gelatin). All plaques 
from single plate were taken, to avoid possible selec-
tion bias. Lambda TriplEx2 plaque elutes (150ul) were 
incubated into 200ul of E.coli BM25.8 overnight cul-
tures in presence of MgCl2 (10mM final concentra-
tion) and incubated at 31˚C for 30 min followed by 
addition of LB medium and another incubation with 
shaking (225rpm) for 1 hr. Infected cell suspensions 
were transferred and spread onto LB ampicillin 
(100mg/ml) plates and incubated overnight at 31°C. 
Sequence analysis 
Plasmid DNA was isolated from the conversion 
clones for plasmid recovery and sequencing. The 
searches for nucleotide, EST and protein sequence 
similarities were conducted with BLAST algorithm at 
the National Center for Biotechnology Information 
(NCBI) (http://www.ncbi.nlm.nih.gov/BLAST/). 
The LvSUMO-1 deduced amino acid sequence was 
analyzed with the NCBI Protein Sequence Analysis 
software. Multiple alignment of the LvSUMO-1 was 
performed with the ClustalX Multiple Alignment 
program (http://www.ncbi.nlm.nih.gov) and Multi-
ple Alignment show by GENEDOC, version 2.6.001 
(31). SUMO modification site was determined by 
SUMOplotTM prediction (http://abgent.com/tools) 
Tissue specificity of SUMO-1 gene expressions in 
L. vannamei  
Total RNA samples were treated for possible 
genomic DNA contamination with DNase I (Invitro-
gent) in a 10 µl reaction containing 1.5 µg of RNA, 1 
µl 10x buffer (200 mM Tris-HCl, pH 8.4, 20 mM 
MgCl2, 500mM KCl), 1.5 µl DNase I (1.5 U) at 37 °C 
for 15 min, followed by inactivation with 25 mM 
EDTA at 65°C for 10 min. Reverse transcription (RT) 
was performed using 1.5 µg RNA, 0.5 µg Oligo (dT) 
18 mers, 1.0 mM dNTP, 4 µl of 5x reaction buffer and 
40 U of M-MuLV reverse transcriptase (Fermentas) at 
37°C for 60 min. The reaction was stopped by heating 
at 70°C for 10 min. For PCR amplification, two oli-
gonucleotide primers, B95_F: 5’-ATGTC 
TGATAACGCTGACGCCAAGCCA-3’and B95_R: 
5’-TCAATGGCCGCCGGTC TGCTCCTGGTA-3’were 
designed based on the nucleotide sequence corre-
sponding to the nucleotide positions 1-27 and 256-282 
of L. vannamei SUMO-1 cDNA, respectively. A set of 
control, elongation factor (EF-1), EF-1_F: 5’- 
GAAGATCGACAGGCGTACTGGTAA 3’and 
EF-1_R: 5’- GGCCTTGGTAGTTTCGCCAGATTGAT 
-3’, served as a control (28) was used during the 
RT-PCR amplification. PCR reactions were conducted 
f o r  4 0  c y c l e s  w i t h  d e n a t u r e  a t  9 4 °C for 30 sec, an-
nealing at 60°C for 30 sec, and extension at 72°C for 
30 sec in a reaction buffer consisting of 10 mM Tris 
(pH 8.3), 50 mM KCl, 200 M dNTPs, 0.2 µM of each 
primer, and 2.5 U of Taq Polymerase (New England 
Biolab) in a total volume of 50 µl. To visualize the 
amplified products, PCR reaction was electrophore-
sed through 1.5% agarose gel containing 0.025% 
ethidium bromide.   
Cytoplasmic and nuclear protein extractions 
150 mg tissue was homogenized in 1 ml buffer A 
(10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA) 
contained 1 µl of each protease inhibitor (1mM DTT, 
0.5mM PMSF, 10µg/µl leupeptin) and 40µl of 10% 
NP40, incubated 10 min at room temperature. Cell 
debases and un-break cell was separated by centrifu-
gation at 4°C at 1,000 g for 3 min. Follow by centrifu-
gation at 4°C at 15,000x g for 3 min, nuclear was 
packed in the bottom of microcentrifuge tube. Su-
pernatant was separated to new tube as the cytosolic 
protein fraction. 150 µl of buffer B (20mM HEPES, pH 
7.9, 0.4 M NaCl, 1mM EDTA, 10% glycerol) was 
added into nuclear pellet. Pellet was resuspended by 
pipeting up and down and shacked vigorously at 4 
°C for 2 hr. Supernatant represented nuclear protein 
fraction was separated by centrifugation at 4°C at 
15,000x g for 5 min. Protein concentration was tested 
by using BCA method (Pierce). 
Western blot analysis 
The cytosolic and nuclear protein were subjected 
to electrophoresis using 15% SDS-PAGE, following 
by Western blotting according to the Mini Tran-Blot 
electrophoretic Transfer cell system (BioRad). Pro-
teins were transferred onto PVDF membrane (Bio 
Rad) in electoblotting buffer (25mM Tris–HCl, 
190mM Glycine, 20% methanol) at a constant current 
of 2.5mA for 2 h. The membrane was immersed in 
blocking buffer (5% nonfat dry milk, 1X Tris buffer 
saline (TBS), pH 7.4, 0.1% Tween 20) at room tem-
perature for 1 hr followed by incubation with rabbit 
polyclonal antibody to human SUMO-1 (c-terminal) 
(Abgent) in antibody dilution buffer (1% nonfat dry 
milk, 1x Tris buffer saline(TBS), pH 7.4, 0.1% Tween Int. J. Biol. Sci. 2009, 5 
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20) at a concentration of 1:500 at 4 C overnight. Sub-
sequently, the membrane was incubated in 
HRP-conjugated anti-rabbit IgG (Santa Cruz) for 2 h 
at a concentration of 1:1000 and developed with 
Visualizer EC western blot detection kit (Millipore). 
Results and Discussion 
L. vannamei SUMO-1 cDNA and amino acid se-
quences homolog 
The cDNA library from abdominal muscle of 
juvenile animals was successfully constructed by a 
PCR-base method. Library titrations were 5.0 x 106 
pfu/ml (27). Phage lift hybridization method was 
used for screening TGF-β family and other related 
proteins by a mixture of six biotin-labeled degener-
ated oligonucleotide DNA probes. A total of 112 
positive clones were isolated and sequenced. One of 
the cDNA sequences (664 nucleotides) showed a high 
homology to SUMO-1, named as LvSUMO-1.  The 
cDNA sequence contains a protein-coding sequence 
of 282 nucleotides and 5’ (37 nucleotides) and 3’ (347 
nucleotides) untranslated regions (Fig. 1). The cDNA 
sequence of LvSUMO-1 was submitted to NCBI 
Genbank (Accession number: FJ751760). The deduced 
sequence of 93 amino acids from LvSUMO-1 cDNA 
has a molecular mass of 10.23 kDa and exhibits 83% 
identity and 89% similarity with the Western Honey-
bee (Apis mellifera) SUMO homolog family member 
Smo-1 (Fig. 2) and 65% identity and 79% similarity 
with human and mouse SUMO-1, respectively. The 
deduced amino acid sequences of 
SUMO proteins from Human, Xenopus, Zebrafish, L. 
vannamei, Brine shrimp, Honeybee, Nematode and 
yeast are aligned in Fig. 2. All SUMO proteins from 
yeast to human share the conserved the C-terminal 
diglycine cleavage/attachment, which is the critical 
domain for SUMO protein maturation and conjuga-
tion (32). The results from sequence alignment also 
revealed that SUMO-1 is highly evolutionarily con-
served from human SUMO-1 to yeast Smt3 proteins, 
particularly the double glycine site. A prominent dif-
ference between the SUMO proteins and ubiquitin is 
the presence of a highly variable N-terminal exten-
sion in SUMO proteins, wherein it includes several 
charged amino acids such as glycines and prolines 
(33). The function of this N-terminal extension in 
SUMOs is not presently known. The homology of 
LvSUMO-1 and SMT3 of Drosophila melanogaster is 
only 45% (Fig. 3). Protein alignment of human 
SUMO1/2/3, mouse SUMO1/2/3, SMT3 Drosophila 
and LvSUMO-1 suggests that LvSUMO-1 has a high 
homology to human and mouse SUMO-1 (Fig. 3). The 
SUMOplot prediction from http://abgent.com/tools 
showed the LvSUMO-1 contains the AKPE motive 
site, which is the sumoylation consensus ψKXE motif 
where ψ is a large hydrophobic residue and X is any 
amino acid in the N-terminal (34). Therefore, the 
name of LvSUMO-1 was assigned to this cDNA se-
quence.  
 
 
Fig.1. Nucleotide and deduced amino acid 
sequences of L. vannamei SUMO-1 
(LvSUMO-1) cDNA. Amino acids are indi-
cated as single capital letters under each 
triplet codon of the nucleotide sequence. 
The start codon is underlined and an aster-
isk (*) indicates the stop codon. Sumo 
modification prediction site on the poly-
peptide chain was showed in capital letters 
(AKPE). The polyadenylation signal 
(ATTAAA) is typed in capital letters under-
lined. Int. J. Biol. Sci. 2009, 5 
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Fig.2. Amino acid sequence alignment among different SUMO-1 proteins. The amino acid sequences of Human (Accession 
no. AAH53528), Xenopus (Accession no. Q6DEP7), Zebrafish (Accession no. Q7SZR5), Brine shrimp: (Accession no. 
ABQ41279), Honeybee (Accession no. XP_392826), Wesp (Accession no. XP_001607301), Nematode (Accession no. 
CAP33470) and yeast (Accession no. NP_010798) are aligned. C-terminal diglycine motif, a site used for propeptide 
processing, is boxed, and the predicted cleavage site is marked by an arrowhead. A glutamine residue known to be important 
for the interaction of human SUMO-1 with protease Senp2 is asterisked.  
 
Fig. 3. Alignment of the LvSUMO-1 (sh1) with those of human SUMO-1 (hu1: GenBank Accession No. NP_003343), human 
SUMO-2(hu2: GenBank Accession No. P61956), human SUMO-3(hu: GenBank Accession No. NP_008867), mouse 
SUMO-1(m1: GenBank Accession No. NP_033486), mouse SUMO-2(m2: GenBank Accession No. NP_579932), mouse 
SUMO-3(m3: GenBank Accession No. Q9Z172) and Drosophilar smt3(dro: GenBank Accession No. NP_477411). Identical 
residues among all sequences are shown in black background and gaps are shown by hyphens. vanSUMO-1 grouped with 
human and mouse SUMO-1, is boxed.  
 
Specific tissue expression of LvSUMO-1 mRNA 
in L. vannamei  
Expressions of LvSUMO-1 in different tissues 
are shown in Fig. 4. LvSUMO-1 mRNA expressions 
were detected in hepatopancrease, haemocytes, gill 
and abdominal muscle with the highest level in 
hepatopancrease and low levels in heart, intestine, 
lymphoid, brain and nerve and pleopods. The 
LvSUMO-1 mRNA was not detected in eyestalk (E), 
swimming leg muscle (SM) and ovary (O). SUMO-1 
mRNA expressions by Northern blot hybridization Int. J. Biol. Sci. 2009, 5 
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had been reported in most mouse tissues, including 
heart, brain, spleen, lung, liver, skeletal muscle, kid-
ney and testis (35). Similarly, the endogenous 
SUMO-1 mRNA expression was found in human 
leukocyte, colon, small intestine, ovary, testis, pros-
tate, thymus and spleen and testis with the testis ex-
hibiting the highest level (8). These data reveal that 
LvSUMO-1 is ubiquitously expressed in many tissues 
in L Vannamei.  
Tissue-specific expressions of LvSUMO-1 pro-
teins  
To confirm the mRNA expressions, the 
LvSUMO-1 proteins expression was detected by us-
ing Western blot analysis (Fig. 5). The antibody to 
SUMO-1 is generated from rabbits immunized with a 
KLH conjugated synthetic peptide selected from the 
C-terminal region of human SUMO1. The cytoplas-
mic and nuclear proteins from different tissues were 
extracted and tested for LvSUMO-1 protein. In the 
cytoplasmic protein fraction, LvSUMO-1 was de-
tected at the position of 10 KD in hepatopancreas, 
heart and intestine tissue (Fig. 5a). The expression of 
LvSUMO-1 protein in nuclear fraction was also de-
tected in hepatopancreas, intestine and lymphoid 
(Fig.5b). In both cytoplasmic and nuclear fractions, 
LvSUMO-1 protein showed a high level of expression 
in hepatopancreas. The protein blot by this antibody 
also showed LvSUMO-1 conjugated protein bands 
since their molecular weight are more 10 KD. The free 
form of LvSUMO-1 protein was not detected in the 
abdominal muscle tissue while several conjugated 
protein signals with higher molecular weights were 
detected in the tissue (Fig.4).   
 
 
Fig.4.  Tissue specificity of LvSUMO-1 gene expression by RT-PCR. LvSUMO was highly expressed in hepatopan-
crease(Hep), haemocytes(Cy), Gill(G) and abdominal muscle(AM) but weakly in heart(H), intestine(I), lymphoid(L), brain 
and nerve(BN) and pleopods(P). Also the expression were undetected in eyestalk (E), swimming leg muscle(SM) and 
ovary(O) in this amount of RNA template. EF-1 gene was used as the internal control. 
 
 
Fig.5.  Western Blot analysis of shrimp 
SUMO-1 transcripts from various tissues 
compost of heart(H), intestine(I), hepa-
topancrease(Hep), haemocytes(Cy), 
lymphoid(L), brain and nerve(BN), 
Gill(G), pleopods(P) and abdominal mus-
cle(AM) in cytosolic and nuclear protein 
fraction(M=protein marker). Protein 
expression level of shrimp SUMO-1 was 
very high expressed in hepatopancreas 
both in cytosilic and nuclear protein 
fraction. In addition, the expression in 
were found in heart and intestine of cy-
toplasmic protein fraction and in intestine 
and lymphoid of nuclear protein fraction.  
 Int. J. Biol. Sci. 2009, 5 
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Most of the SUMO-1 protein was previously 
shown to localized on nuclear membrane (36, 37). 
Unlike SUMO-2/3 that has an apparent free form, 
human SUMO-1 has no free form to be detected (33). 
The LvSUMO-1 protein was detected in free form in 
intestine and hepatopancreas of cytosolic fraction and 
in hepatopancrease and lymphoid of nuclear fraction, 
which are more like the human SUMO-2/3. Many of 
sumolylated proteins have been found. For example, 
SUMO-1 is believed to form an isopeptide bond be-
tween the carboxyl terminus of SUMO-1 and a lysine 
side chain(s) of the target protein (2, 9, 32). All SUMO 
forms are initially processed as inactive precursors, 
then mature by a carboxy-terminal proteolytic cleav-
age event, which yields the mature modifiers with 
exposed carboxy-terminal glycine residues. These 
residues are required for the formation of and 
isopeptide bond between the carboxyl terminus of 
SUMO with an ε-amino group of lysine residue of a 
target protein. The processing reaction is catalyzed by 
a group of cysteine proteases, termed ULPs (ubiq-
uitin-like protein-processing enzyme) or 
SUMO-specific proteases (3). The mechanism of 
SUMO conjugation has been proposed by Ronald T. 
Hay (38), which consists of three enzymes cascade 
involving a Ubl activating enzyme(E1), a Ubl conju-
gating enzyme(E2), and typically a Ubl protein li-
gase(E3). To initiate the SUMO modification reaction, 
activating enzyme catalyzes the formation of ade-
nylated SUMO in which the C-terminal carboxyl 
group of SUMO is covalently linked to AMP. SUMO 
was transesterified to conjugating enzyme. The con-
jugating enzyme called Ubc9 can directly recognize 
substrate protein that contain the SUMO modification 
consensus motif, ψKXE motif (39). In the case of 
LvSUMO-1 conjugation, the polymeric SUMO chain 
may happen because it contains SUMO modification 
consensus motif. However several key enzymes such 
as ligase (E3) in the pathways has been reported in 
shrimp or crustacean yet.   
LvSUMO-1 mRNA expression and shrimp mus-
cle development  
The  LvSUMO-1 was originally identified from 
shrimp muscle cDNA library. Its mRNA expression 
can be easily detected by RT-PCR although only su-
moylated proteins were detected in the abdominal 
muscle tissue by Western blotting. Therefore, we 
performed RT-PCR to study the function of 
LvSUMO-1 expression in shrimp muscle tissue in-
stead of western blot analysis. The developmental 
and life cycle of L. vannamei can be classified to seven 
stages, including egg, nauplius, protozoea, mysis, 
postlarva and juvenile and adult (40). Muscle forma-
tion in dendrobranchiate shrimp was reported by 
Kiernan and Hertzler (41). In the dendrobranchiate 
malacostracan  Sicyonia ingentis, F-actin staining was 
first detected in limb setae at 12 h. Staining of F-actin 
was detected in the trunk at 15 h and grew into nau-
pliar limbs. Sarcomeres were detected at 19 h, identi-
fying the structures as extrinsic limp muscles. The 
extrinsic limb muscles enlarged but retain their gen-
eral pattern during the later nauplius stages. Longi-
tudinal trunk muscle and circumferential visceral 
muscle developed in the post-naupliar region during 
nauplius instars 4 and 5, at the time when the gut also 
formed. Among decapod malacostracan larvae, ab-
dominal muscle development was described in zuea 
and mysis larvae of the caridean shrimp Crangon vul-
garis (42). And the adult muscle of dendrobranchiate 
shrimp Penaeus (Litopenaeus) setiferus have been care-
fully examined (43).   
In this study, we sampled shrimp tissue over 
several developmental stages, mainly nauplius as the 
larva stage, postlarva and juvenile to study 
LvSUMO-1 expression. The LvSUMO-1  mRNA ex-
pression was detected in a low level in nauplius 
(Nau) stage and then followed by increased 
up-regulation in postlarva(PL) stage 1, 10 and 19. The 
expression was also presented in juvenile (Jn) (Fig.6). 
These results indicate that LvSUMO-1 was 
up-regulated during the muscle formation. Other 
studies have showed that sumoylation of SnoN by 
SUMO-1 plays a role in TGF-β signaling, which is 
known to regulate myogenesis. The over-expression 
of c-Ski/SnoN induces skeletal muscle differentiation 
(44, 45). Loss of sumoylation activates muscle-specific 
gene expression and enhanced myotube formation 
(25). Most regulatory genes related to shrimp muscle 
formation and development are not known. This 
study suggests possible target protein by LvSUMO-1 
modification may play a role in the regulation of 
shrimp myogenic differentiation and muscle forma-
tion. 
Growth in shrimps, like other crustacean, is in-
termittent, and muscle mass accumulation occurs 
through molting-shedding of exoskeleton (46, 47). 
Muscle morphology and biochemical changes of L. 
vannamei during molting process have been studied 
by Yang and his research group (28, 48). Muscle 
structural  α-actin and cytoskeleton β-actin were in-
creased during intermolt and premolt stage, suggest-
ing high muscle growth during these stages. How-
ever, the mRNA encoding for ubiquitin and Hsp70 
did not increase significantly in premolt stages. In 
this study, three molting stages, including postmolt, 
intermolt and premolt, were used for RNA extraction. 
The  LvSUMO-1 transcript was detected in the ab-Int. J. Biol. Sci. 2009, 5 
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dominal muscle tissue in all molting stages tested. 
The LvSUMO-1 mRNA expression was high at pre-
molt (C) stage, and low during postmolt stage (A) 
and intermolt stages (B) (Fig. 7). The LvSUMO-1 ex-
pression in intermolt stage is much lower than in 
postmolt stage. As the overall muscle protein synthe-
sis is higher in intermolt than in postmolt (46), the 
result may indicate that LvSUMO-1 play an impor-
tant role in the regulation of muscle protein synthesis 
and degradation during the molt cycle. Further com-
parisons of LvSUMO-1 and ubiquitin during molting 
stage are needed to clarify their expression patterns 
in relation to protein accumulation during shrimp 
molt cycle.   
 
 
Fig.6. Differentiation stage of shrimp SUMO-1 gene expression by RT-PCR (Nau=nauplius, PL1= postlarvae 1 day, PL10= 
postlarvae 10 days, PL19= postlarvae 19 day and Adu= adult). The expression level is up regulated in all postlavae stated and 
adult.  
 
 
 
Fig.7. Shrimp SUMO-1 gene expression in different molting stage by RT-PCR. (A= postmolt, B=intermolt, C=premolt). 
SUMO-1 mRNA level is low expressed between postmolt and intermolt but high expressed in premolt.  
 Int. J. Biol. Sci. 2009, 5 
 
 
http://www.biolsci.org 
213
Conclusions 
LvSUMO-1 cDNA contains a protein-coding se-
quence of 282 nucleotides and 37 untranslated nu-
cleotides at 5’ and 347 untranslated nucleotides at 3’ 
ends. The deduced 93 amino acids was found to ex-
hibit 83% identity with the Western Honeybee 
SUMO-1 and 65% identity with human and mouse 
SUMO-1. The homology of LvSUMO-1 and of Droso-
phila melanogaster S U M O - 1  ( S M T 3 )  i s  o n l y  4 5 % .  
LvSUMO-1 has a sumoylation motif that is conserved 
from mouse to human. This is the first report of 
SUMO-1 in crustacean species. The expression of 
LvSUMO-1 mRNA was identified in most shrimp 
tissues. LvSUMO-1 protein was found in both cyto-
plasm and nucleus while mostly detectable proteins 
were located in cytoplasm. By using SUMO-1 anti-
body detection, the free form of LvSUMO-1 protein 
was detected mostly in hepatopancreas, cytosolic and 
lymphoid. Several SUMO-1 conjugated proteins were 
detected in abdominal muscle tissue. LvSUMO-1 level 
also showed a progressive increase over the early 
developmental stages. The expression patterns in 
abdominal muscle during the molt cycle indicate that 
LvSUMO-1 may be involved in the regulation of 
muscle protein synthesis and degradation in shrimp.   
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